Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones

Development of resistance to endocrine therapy is a clinical issue in estrogen receptor (ER)-positive breast cancer. Here we show that persistent activation of AKT/mTOR signaling is crucial to the acquisition of letrozole resistance in cell clones generated from MCF-7/AROM-1 aromatase-expressing bre...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Cavazzoni, A, Bonelli, M, Fumarola, C, La Monica, S, Airoud, K, Bertoni, R, Alfieri, R, Galetti, M, Tramonti, S, Galvani, E, Harris, A, Martin, L, Andreis, D, Bottini, A, Generali, D, Petronini, P
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2012

Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. -н Cavazzoni, A, Bonelli, M, Fumarola, C, La Monica, S, Airoud, K, Bertoni, R, Alfieri, R, Galetti, M, Tramonti, S, Galvani, E, Harris, A, Martin, L, Andreis, D, Bottini, A, Generali, D, Petronini, P

Хэвлэсэн 2012

Journal article

Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones

Ижил төстэй зүйлс